Relative BIRC3 gene expression in chronic lymphocytic leukemia
Open Access
- 1 January 2026
- journal article
- Published by Centre for Evaluation in Education and Science (CEON/CEES) in Journal of Medical Biochemistry
- Vol. 45 (11) , 2458-2464
Abstract
Background: Chronic lymphocytic leukemia (CLL) represents the most frequent type of leukemia in the adult population. It is characterized by highly variable clinical course, predominantly initiated by different genetic alterations responsible for the regulation of cell proliferation and apoptosis. The aim of this study was to evaluate the relative expression of the BIRC3 gene in CLL patients. Methods: This cross-sectional study included 78 participants: a CLL group (n=50) and a control group of healthy subjects (n=28), both ageand sex-matched. To all participants, CBC (complete blood count), basic biochemical parameters, as well as FISH (fluorescent in situ hybridisation) for determining chromosomal aberrations and PCR analyses for determining the relative expression of the BIRC3 (Baculoviral IAP Repeat Containing 3) gene were performed. All reactions were performed on QIA quant 96 5 plex real-time PCR instrument (Qiagen, Hilden, Germany). Additionally, FISH diagnostics was performed using Abbott Vysis CLL FISH Probe Kit (Abbott Molecular diagnostics, Chicago, IL, USA). Results: Deletion of the long arm of the 13th chromosome was the most frequent chromosomal aberration in the CLL group. A statistically significant difference was observed in the relative expression of BIRC3, with higher values in the study group (p=0.019). The results of the binary logistic regression model indicated that lactate dehydrogenase and total calcium were statistically significant predictors of relative BIRC3 gene expression (p < 0.05). Conclusion: Determination of relative BIRC3 gene expression may be a valuable analysis for both the initial diagnosis and the clinical follow-up of CLL patients.Keywords
This publication has 24 references indexed in Scilit:
- Chronic lymphocytic leukemia: 2022 update on diagnostic and therapeutic proceduresAmerican Journal of Hematology, 2021
- Unmet supportive care needs, anxiety and depression in haematology patients during watch‐and‐waitPsycho-Oncology, 2021
- The complex karyotype and chronic lymphocytic leukemia: prognostic value and diagnostic recommendationsAmerican Journal of Hematology, 2020
- Genomic and Epigenomic Alterations in Chronic Lymphocytic LeukemiaAnnual Review of Pathology: Mechanisms of Disease, 2020
- BIRC3 Expression Predicts CLL Progression and Defines Treatment Sensitivity via Enhanced NF-κB Nuclear TranslocationClinical Cancer Research, 2019
- BIRC3 is a novel driver of therapeutic resistance in GlioblastomaScientific Reports, 2016
- The Actual Role of LDH as Tumor Marker, Biochemical and Clinical Aspects2015
- The Pathogenesis of Chronic Lymphocytic LeukemiaAnnual Review of Pathology: Mechanisms of Disease, 2014
- Expression of Bcl2L12 in chronic lymphocytic leukemia patients: association with clinical and molecular prognostic markersMedical Oncology, 2013
- Analysis of CD23 antigen expression in B-chronic lymphocytic leukaemia and its correlation with clinical parametersMedical Oncology, 2008